Evidence map›Paper›PMID 29773792›Full record

ArticleNature communications2018

MxB is an interferon-induced restriction factor of human herpesviruses.

Michel Crameri, Michael Bauer, Nicole Caduff, Raphael Walker, Fiona Steiner, Francesca D Franzoso, Cornelia Gujer, Karin Boucke, Talissa Kucera, Andrea Zbinden and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 130 citations in OpenAlex.

  1. Expulsion of nuclear DNA to the cytoplasm after viral entry: A mechanism for activation of the cGAS pathway.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. MX2 Mediates Collapse of the HIV-1 Capsid.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Antiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Michel CrameriInstitute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Michael BauerLife Science Zurich Graduate School, Winterthurerstrasse 190, 8057, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-8156-4603
Nicole CaduffLife Science Zurich Graduate School, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Raphael WalkerInstitute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Fiona SteinerInstitute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Francesca D FranzosoInstitute of Virology, University of Zurich, Winterthurerstrasse 266a, 8057, Zürich, Switzerland.
Cornelia GujerInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Karin BouckeInstitute of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Talissa KuceraInstitute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Andrea ZbindenInstitute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Christian MünzInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.
Cornel FraefelInstitute of Virology, University of Zurich, Winterthurerstrasse 266a, 8057, Zürich, Switzerland.
Urs F GreberInstitute of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-2278-120X
Jovan PavlovicInstitute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zürich, Switzerland. pavlovic.jovan@virology.uzh.ch.
University of Zurich · CHZHAW Zurich University of Applied Sciences · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The type I interferon (IFN) system plays an important role in controlling herpesvirus infections, but it is unclear which IFN-mediated effectors interfere with herpesvirus replication. Here we report that human myxovirus resistance protein B (MxB, also designated Mx2) is a potent human herpesvirus restriction factor in the context of IFN. We demonstrate that ectopic MxB expression restricts a range of herpesviruses from the Alphaherpesvirinae and Gammaherpesvirinae, including herpes simplex virus 1 and 2 (HSV-1 and HSV-2), and Kaposi's sarcoma-associated herpesvirus (KSHV). MxB restriction of HSV-1 and HSV-2 requires GTPase function, in contrast to restriction of lentiviruses. MxB inhibits the delivery of incoming HSV-1 DNA to the nucleus and the appearance of empty capsids, but not the capsid delivery to the cytoplasm or tegument dissociation from the capsid. Our study identifies MxB as a potent pan-herpesvirus restriction factor which blocks the uncoating of viral DNA from the incoming viral capsid.

Indexed as

CapsidCapsid ProteinsCell Line, TumorCell NucleusCytoplasmDNA, ViralHEK293 CellsHerpesviridaeHerpesviridae InfectionsHumansInterferon Type IMyxovirus Resistance ProteinsRNA, Small InterferingVirus ReplicationVirus UncoatingCapsid ProteinsDNA, ViralInterferon Type IMX2 protein, humanMyxovirus Resistance ProteinsRNA, Small Interfering

Identifiers

PMID29773792
PMCPMC5958057
OpenAlexW2803453391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.